Novo Nordisk's Obesity Shot Trial Misses Mark
Novo Nordisk A/S faces a setback with disappointing trial results for its obesity shot, marking a turbulent year for the pharmaceutical giant.
Novo Nordisk A/S saw disappointing trial results for an obesity shot, capping a volatile year.